Are you Mina M. Naguib, M.D.? This profile is yours to edit: update your address, phone, photo and services.
Edit this profileBased in New York, NY, Mina M. Naguib, M.D. is listed in the NPI registry under ophthalmology. Mina graduated from Emory University School of Medicine in 2017. Medicare claims data shows Mina provided 925 services to 314 patients. The services billed most often include injection, aflibercept hd, 1 mg, established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more, and imaging of retina. NPI 1891220539 identifies this record in the national registry.
Factual summary compiled by Guide.md from public records; not written by this provider.
Exactly as CMS reports it (National Downloadable File, Opt-Out Affidavits, Order & Referring). Not an insurance directory; confirm coverage with the office.
222 E 41ST ST
New York, NY 10017
Within Ophthalmology generally. Availability varies by clinician, training and location — this profile has not been claimed, so nothing here is a personal claim by the provider.
Eye injury and cancer
Inflammation, neurologic, and orbit
Most searched conditions
Cornea and external eye
Eyelid and tear drainage
Refractive and focusing
Retina and vitreous
Eye injuries
Retina & vitreous
Cataract and lens
Cornea and refractive
Emergency and minor
Examination and imaging
Eyelid, tear duct, and muscle
Glaucoma
Retina
Most searched procedures
Corneal procedures
Eye diagnostics
Eye injuries
Eyelid surgery
Laser eye surgery
Laser procedures
Laser vision correction
Refractive surgery
Tear duct & Orbit
925 services · 314 patients · 6 distinct codes
| Procedure | Type | Code | Services | Compared with peers |
|---|---|---|---|---|
| Injection of drug into eye | Procedure | 67028 |
103 | Less often than most peers in Ophthalmology |
| Imaging of retina | Treatment | 92134 |
136 | As often as other peers in Ophthalmology |
| Photography of the retina | Treatment | 92250 |
124 | As often as other peers in Ophthalmology |
| Injection, aflibercept hd, 1 mg | Drug given | J0177 |
304 | Less often than most peers in Ophthalmology |
| Injection, aflibercept, 1 mg | Drug given | J0178 |
60 | Less often than most peers in Ophthalmology |
| Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | Office visit | 99214 |
198 | As often as other peers in Ophthalmology |
Source: CMS Medicare public data. Shows how often procedures were billed — not quality of care or patient satisfaction.
Mina M. Naguib is an eye doctor in New York, NY. That is the designation recorded for this NPI in the federal registry, where it is listed as “Ophthalmology”.
NPI registry
Mina M. Naguib is listed at 222 E 41St St, New York, NY 10017. Addresses come from the NPI registry and can lag a move, so confirm before travelling.
NPI registry
The number on file is (212) 263-2573. Contact the office directly to confirm availability and scheduling.
NPI registry
Mina M. Naguib's National Provider Identifier is 1891220539. It is issued by the Centers for Medicare & Medicaid Services and is unique and permanent — it does not change if they move practice.
NPI registry
Mina M. Naguib attended Emory University School of Medicine, graduating in 2017. This comes from the CMS National Downloadable File.
CMS public data
Mina M. Naguib has 9 years experience. Calculated from a graduation year of 2017, reported in the CMS National Downloadable File.
CMS public data
According to Medicare billing data, Mina M. Naguib performs procedures including injection of drug into eye; provides treatments such as imaging of retina and photography of the retina, alongside routine visits and testing. This reflects Medicare patients only and is billing volume, not a measure of quality.
Medicare claims
Not yet. This profile is built from public federal data and has not been confirmed by Mina M. Naguib. If this is you, claiming it is free.
Guide.md
Guide.md listings do not constitute medical advice or an endorsement.
A GigHz company · Founder: Pouyan Golshani, MD